2011
DOI: 10.1007/s12272-011-0107-2
|View full text |Cite
|
Sign up to set email alerts
|

simultaneous determination of mycophenolic acid and its metabolites by HPLC and pharmacokinetic studies in rat plasma and bile

Abstract: In this study, we determined the pharmacokinetics of mycophenolic acid (MPA) and its metabolites mycophenolic acid glucuronide (MPAG) and acyl glucuronide (AcMPAG) in rat plasma and bile, using a newly developed HPLC method. Protein precipitation and liquid-liquid extraction were employed in sample preparation of plasma and bile, respectively. The HPLC methods included a gradient elution consisting of acetonitrile and phosphate buffer at a flow rate of 1.2 mL/min, with UV detection at 254 nm. The HPLC method w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
21
0

Year Published

2013
2013
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(22 citation statements)
references
References 26 publications
1
21
0
Order By: Relevance
“…20) In humans and rats, MMF is also known to exhibit EHC of MPA because its metabolite MPAG undergoes biliary excretion followed by deconjugation to MPA in the GI tract and absorption to the blood. 19,21) Since MMF is commonly administered in combination with other agents such as calcineurin inhibitors and steroids, many DDIs are reported. For example, co-delivery of cyclosporin A (CysA) can reduce plasma MPA concentration because CysA is believed to inhibit biliary excretion of MPAG, resulting in reduced EHC of MPA.…”
Section: Introductionmentioning
confidence: 99%
“…20) In humans and rats, MMF is also known to exhibit EHC of MPA because its metabolite MPAG undergoes biliary excretion followed by deconjugation to MPA in the GI tract and absorption to the blood. 19,21) Since MMF is commonly administered in combination with other agents such as calcineurin inhibitors and steroids, many DDIs are reported. For example, co-delivery of cyclosporin A (CysA) can reduce plasma MPA concentration because CysA is believed to inhibit biliary excretion of MPAG, resulting in reduced EHC of MPA.…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, oral MMF administration to Sprague–Dawley (SD) rats yields a recovery of 33% of MPAG, 0.08% of MPA, and 1.06% of AcMPAG in the bile (Gao et al. ). It is also reported that intravenous dosing of MPA to Wistar rats yields 66% of MPAG biliary recovery (Ishizaki et al.…”
Section: Introductionmentioning
confidence: 99%
“…In contrast to humans, urinary recovery of MPAG is reported to be only 55% in normal adult Wistar rats (Ishizaki et al 2012) following intravenous injection of MPA. Furthermore, oral MMF administration to Sprague-Dawley (SD) rats yields a recovery of 33% of MPAG, 0.08% of MPA, and 1.06% of AcMPAG in the bile (Gao et al 2011). It is also reported that intravenous dosing of MPA to Wistar rats yields 66% of MPAG biliary recovery (Ishizaki et al 2012).…”
Section: Introductionmentioning
confidence: 99%
“…3 MP is available for oral administration as capsules containing 250 mg and 500 mg. Literature survey reveals, many HPLC [4][5][6] and LC-MS/MS 7-15 based methods have been reported for the determination of MPA in biological samples. Similarly, very few HPLC methods have been reported for the determination of MP alone 16 and in combination with MPA.…”
Section: Introductionmentioning
confidence: 99%